Nargiza Parpieva

49 works

Tashkent Medical Academy , Tashkent, Uzbekistan

1. Detection of Nontuberculosis Mycobacteria in National Reference Laboratory (NRL) of Uzbekistan

   Sanjar Sultanov, Nargiza Parpieva, Kazim Mukhamedov +3

   ArticleMycobacterium research and diagnosisTuberculosis20200 citations

   ABIABI:AkademIndex/openalex/2020.article.003374

2. Adverse Drug Reactions among Children with Tuberculosis in Tashkent, Uzbekistan, 2019

   Makhliyo Abdusalomova, Olga Denisiuk, Hayk Davtyan +4

   ArticleTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20210 citations

   ABIABI:AkademIndex/openalex/2021.article.000364

3. Treatment Outcomes of Isoniazid-Resistant (Rifampicin Susceptible) Tuberculosis Patients in Uzbekistan, 2017–2018

   Zayniddin Sayfutdinov, Ajay Kumar, Dilyara Nabirova +5

   ArticleTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20210 citations

   ABIABI:AkademIndex/openalex/2021.article.000692

4. Incidence Rate and Risk Factors for Tuberculosis among People Living with HIV: A 2015–2017 Cohort from Tashkent, Uzbekistan

   Dilbar Sadirova, Ruzanna Grigoryan, Nargiza Parpieva +9

   ArticlePneumocystis jirovecii pneumonia detection and treatmentInternational Journal of Environmental Research and Public Health20210 citations

   ABIABI:AkademIndex/openalex/2021.article.000698

5. Characteristics and Treatment Outcomes of Patients with Tuberculosis Receiving Adjunctive Surgery in Uzbekistan

   Anvar Riskiyev, Ana Ciobanu, Arax Hovhannesyan +3

   ArticleDiagnosis and treatment of tuberculosisInternational Journal of Environmental Research and Public Health20210 citations

   ABIABI:AkademIndex/openalex/2021.article.000700

6. Universal Access to Xpert MTB/RIF Testing for Diagnosis of Tuberculosis in Uzbekistan: How Well Are We Doing?

   Laziz Turaev, Ajay Kumar, Dilyara Nabirova +3

   ArticleTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20210 citations

   ABIABI:AkademIndex/openalex/2021.article.001408

7. Adherence of drug-resistant tuberculosis patients to treatment in Tashkent, 2019-2020

   Ruzilya Usmanova, Nargiza Parpieva, Irina Liverko +3

   ArticleTuberculosis Research and Epidemiology20210 citations

   ABIABI:AkademIndex/openalex/2021.article.002154

8. Hospitalizations and Treatment Outcomes in Patients with Urogenital Tuberculosis in Tashkent, Uzbekistan, 2016–2018

   Bakhtiyor Ismatov, Yuliia Sereda, S Sahakyan +2

   ArticleTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20210 citations

   ABIABI:AkademIndex/openalex/2021.article.002301

9. Accuracy of molecular drug susceptibility testing amongst tuberculosis patients in Karakalpakstan, Uzbekistan

   Horacio Gil, Hasmik Margaryan, I. Azamat +8

   ArticleTuberculosis Research and EpidemiologyTropical Medicine & International Health20210 citations

   ABIABI:AkademIndex/openalex/2021.article.003743

10. Non-tuberculous mycobacteria in phthisiopulmonary practice in the Republic of Uzbekistan

    Nargiza Parpieva, S Sultanov, M. Kh. Dzhurabaeva +1

    ArticleMycobacterium research and diagnosisTuberculosis and lung diseases20210 citations

    ABIABI:AkademIndex/openalex/2021.article.004945

11. Treatment of multidrug-resistant tuberculosis in Uzbekistan from 2012 to 2018: does practice follow policy?

    Ruzilya Usmanova, Nargiza Parpieva, Irina Liverko +8

    ArticleTuberculosis Research and Epidemiology20210 citations

    ABIABI:AkademIndex/openalex/2021.article.010203

12. Is Xpert MTB/Rif Ultra superior to Xpert MTB/Rif for the diagnosis of tuberculosis in children in Uzbekistan

    Sanjar Sultanov, Nargiza Parpieva, Kozim Mukhamedov +3

    ArticleIdeological and Political Education20210 citations

    ABIABI:AkademIndex/openalex/2021.article.010211

13. Operational Research to Inform Programmatic Approaches to the Management of Tuberculosis in Uzbekistan

    Jamshid Gadoev, Anthony Harries, Oleksandr Korotych +7

    EditorialDiverse Scientific Research StudiesInternational Journal of Environmental Research and Public Health20210 citations

    ABIABI:AkademIndex/openalex/2021.editorial.000002

14. The impact of the COVID-19 pandemic on tuberculosis detection in Tashkent, Uzbekistan

    Ruzilya Usmanova, Nargiza Parpieva, Irina Liverko +6

    ArticleDiverse Scientific Research Studies20230 citations

    ABIABI:AkademIndex/openalex/2023.article.011428

15. Introducing BPaL: Experiences from countries supported under the LIFT-TB project

    D. F. Wares, M. Mbenga, Veriko Mirtskhulava +19

    ArticleTuberculosis Research and EpidemiologyPLoS ONE20240 citations

    ABIABI:AkademIndex/openalex/2024.article.000471

16. How much should we still worry about QTc prolongation in rifampicin-resistant tuberculosis? ECG findings from TB-PRACTECAL clinical trial

    Ilaria Motta, Martina Cusinato, Andrew Ludman +15

    ArticleCardiac electrophysiology and arrhythmiasAntimicrobial Agents and Chemotherapy20240 citations

    ABIABI:AkademIndex/openalex/2024.article.000869

17. Second-line drug-resistant TB and associated risk factors in Karakalpakstan, Uzbekistan

    S. Moe, I. Azamat, Sholpan Allamuratova +14

    ArticleTuberculosis Research and EpidemiologyIJTLD OPEN20240 citations

    ABIABI:AkademIndex/openalex/2024.article.001030

18. Study the Occurrence of Mycobacterium Bovis in Tuberculosis of Peripheral Lymph Nodes and its Effect on the Course of the Disease.

    Nargiza Parpieva, Askar Anvarovich Adilkhodzhaev, Zarifa Abdiraubovna Muminova

    ArticleTuberculosis Research and EpidemiologyBiomedical & Pharmacology Journal20240 citations

    ABIABI:AkademIndex/openalex/2024.article.008353

19. Features of colposcopy in patients with various forms of pulmonary tuberculosis

    Marufdjon Yuldashev, Nargiza Parpieva, Shaxnoza Zufarova

    ArticleDiagnosis and treatment of tuberculosis20240 citations

    ABIABI:AkademIndex/openalex/2024.article.008686

20. The effectiveness of pulmonary tuberculosis treatment during the COVID-19 pandemic

    Ruzilya Usmanova, Nargiza Parpieva, Irina Liverko +6

    ArticleCOVID-19 Prevention and Impact20240 citations

    ABIABI:AkademIndex/openalex/2024.article.008693

21. A 10-year review of isoniazid-resistant TB management in Uzbekistan 2009-2020

    Michael L. Rekart, Phone Thit, Modupe Oluya +14

    Review articleTuberculosis Research and EpidemiologyIJTLD OPEN20240 citations

    ABIABI:AkademIndex/openalex/2024.review-article.000146

22. The Effectiveness and Safety of Bedaquiline, Pretomanid, and Linezolid (BPaL)–Based Regimens for Rifampicin-Resistant Tuberculosis in Non-Trial Settings—A Prospective Cohort Study in Belarus and Uzbekistan

    Animesh A. Sinha, Robert J. Klebe, Michael L. Rekart +22

    ArticleTuberculosis Research and EpidemiologyClinical Infectious Diseases20250 citations

    ABIABI:AkademIndex/openalex/2025.article.000230

23. Evaluation of TB treatment outcomes in outpatient settings during the COVID-19 pandemic

    Ruzilya Usmanova, Nargiza Parpieva, Irina Liverko

    ArticleTuberculosis Research and Epidemiology20250 citations

    ABIABI:AkademIndex/openalex/2025.article.010588

24. Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysis

    Anthony J. Garcia‐Prats, Maria Garcia‐Cremades, Vivian Cox +97

    Review articleTuberculosis Research and EpidemiologyThe Lancet Child & Adolescent Health20250 citations

    ABIABI:AkademIndex/openalex/2025.review-article.000036